RESUMEN
BACKGROUND: Thrombomodulin (TM) is a glycoprotein and besides its anticoagulant property it is accepted as an onco developmental antigen. Considering these properties we hypothesised that active TMB might have a role in cancer cell behaviour. METHODS: We measured serum TMB levels by the enzyme immunoassay method in 40 patients with lung cancer and 20 healthy subjects. RESULTS: TMB levels were found as 54.6 +/- 11.5 in controls and 60.9 +/- 31.2 ng/ml in lung cancer patients TM levels were 59.4 +/- 24.2 ng/ml in 24 epidermoid carcinoma patients, 65 +/- 50.2 ng/ml in 10 small cell carcinoma patients and 60 +/- 18.4 ng/ml in 6 adenocarcinoma patients. Patients with stage 4 and distant metastasis had a value of 65 +/- 33.9 ng/ml. No significant differences were found between healthy subjects and cancer patients. Also the differences between 3 groups of patients were insignificant. CONCLUSIONS: It was concluded that serum TMB levels could not be accepted as a tumour marker in lung cancer patients.
Asunto(s)
Biomarcadores de Tumor/sangre , Neoplasias Pulmonares/sangre , Trombomodulina/sangre , Adulto , Anciano , Femenino , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana EdadRESUMEN
The study was carried out on 25 women with breast cancer, 25 with fibrocystic breast disease and 19 healthy subjects. Antioxidant enzyme activities and total antioxidant status (AOX) were measured in erythrocyte and plasma of patients and healthies. Among the studied parameters, the erythrocyte Glutathione Peroxidase (GSH-Px) and Catalase (CAT) activities of patients with breast cancer were significantly different as compared to the control group values (p < 0.002 and p < 0.001) respectively. There was no correlation between total antioxidant status and any of these enzymes in erythrocyte and plasma activities of subjects. However, the positive correlation was found between erythrocyte and plasma Superoxide Dismutase [SOD(CuZn)] activities in all groups. Our results indicate that enzymatic and nonenzymatic antioxidants are differentially altered in human breast tumors. Since the total antioxidant status measurement isn't sufficient to evaluate the oxidant damage in breast disease, antioxidant enzymes must be measured separately in order to get additional information.
Asunto(s)
Antioxidantes/análisis , Neoplasias de la Mama/sangre , Enfermedad Fibroquística de la Mama/sangre , Adolescente , Adulto , Anciano , Catalasa/análisis , Eritrocitos/química , Femenino , Glutatión Peroxidasa/análisis , Humanos , Persona de Mediana Edad , Plasma/química , Superóxido Dismutasa/análisisRESUMEN
This study was carried out to investigate the effect of selenium supplementation at a therapeutic level on the isolated ileum contractions and the acetylcholine responses in New Zealand rabbits. While no difference with respect to the controls was found in the spontaneous ileum contraction frequencies a significant increase in the contraction amplitude was noted after 15 days of supplementation. Increasing concentrations of acetylcholine in the perfusion solution resulted in a significant increase of the contraction amplitudes in the supplemented animals as compared to controls. The tissue selenium levels and the gluthathione peroxidase activities were also found significantly higher than the controls. No difference was observed between the contraction numbers in the two groups. These findings indicate that selenium supplementation does not influence the smooth muscle resting potential.
Asunto(s)
Acetilcolina/farmacología , Músculo Liso/efectos de los fármacos , Selenio/farmacología , Animales , Glutatión Peroxidasa/metabolismo , Íleon/efectos de los fármacos , Técnicas In Vitro , Masculino , Contracción Muscular/efectos de los fármacos , Músculo Liso/enzimología , ConejosRESUMEN
Plasma and erythrocyte selenium levels in rabbits supplemented with therapeutic doses of selenium were studied by Zeeman graphite furnace atomic absorption spectrometry using a new palladium-ascorbic acid chemical modifier in order to achieve a higher precision. An improved coupled test procedure was used to determine the glutathione peroxidase (GSH-Px) activities. Superoxide dismutase activities were measured employing a method for the clinical assay of the enzyme. The selenium levels and GSH-Px activities both in the plasma and erythrocytes were higher in the supplemented group when compared to the controls. The SOD activities were increased in the erythrocytes but remained unchanged in the plasma. Or the other hand, a higher copper/zinc ratio was found both in the plasma and erythrocytes of the supplemented group. These findings support the importance of the dietary selenium intake in terms of the principal role of selenium in the cellular antioxidative mechanisms and imply that measurements of plasma selenium levels may be a notable sensitive indicator of the short-term selenium status.
Asunto(s)
Eritrocitos/metabolismo , Glutatión Peroxidasa/sangre , Selenio/sangre , Selenio/farmacología , Superóxido Dismutasa/sangre , Animales , Antioxidantes , Cobre/sangre , Dieta , Masculino , Plasma/metabolismo , Conejos , Selenio/administración & dosificación , Espectrofotometría Atómica , Zinc/sangreRESUMEN
Selenium, aluminum, cadmium, and magnesium concentrations and glutathione-peroxidase activities in sera of 35 healthy individuals, 30 renal transplants, and 30 hemodialysis patients were measured. Serum selenium, aluminum, and cadmium concentrations in both groups of patients were higher than the controls (p less than 0.001), whereas the serum glutathione-peroxidase levels were lower (p less than 0.001). According to our results, it can be concluded that the patients receiving hemodialysis are subjected to more toxic elements than the transplantation patients. These findings imply that dietary selenium supplement may be suggested in renal failure for the detoxification of elements, such as cadmium and mercury. The essential trace element selenium takes part not only in the direct protection of endothelial cells against the accumulation of aggressive oxygen species, but also in the prevention of the toxic effects of cadmium or in the modulation of the active calcium transport.